Skip to main content

Table 1 Expression of plectin in the whole cohort, the N0, T1 and T1N0 patients at time of diagnosis. The number of patients with a 5 year disease specific death (DSD) is given in numbers and also as percentage of total in each group of total in each group

From: Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma

  

Plectin

  

Low expression

High expression

DSDp

All patientsa

N (% of total)

55

56

 

5-year DSD

19 (35 %)

25 (45 %)

0.198

N0-casesb

N (% of total)

36

32

 

5-year DSD

5 (14 %)

13 (41 %)

0.008*

T1-casesc

N (% of total)

23

16

 

5-year DSD

2 (9 %)

6 (38 %)

0.031*

T1N0-casesd

N (% of total)

19

9

 

5-year DSD

0

4 (44 %)

<0.001*

  1. atotal number of patients included in the analysis was 111
  2. btotal number of patients included in the analysis was 68
  3. ctotal number of patients included in the analysis was 39
  4. dtotal number of patients included in the analysis was 28
  5. *p < 0.05 was regarded as statistically significant, and highlighted in boldsface when present